AFP and neoplasm: A total of 74 patients were excluded because of the absence of HCC before LT (52 patients), the absence of HCC in pathology (14 patients), receiving a deceased donor LT (5 patients), missing data on tumour diameter (1 patient), missing data on AFP (1 patient), or missing data on pathology (1 patient).